Browse drugs

…). Long-term survival was similar (stratified log-rank p=0.79). OPCABG mitigated the risk of in-hospital mortality in females (1.1% ma…

…C 2021 criteria, while nine met ILE criteria. During follow-up, hydroxychloroquine was used in 14 patients, csDMARDs in 9, JAK inhibitors in 10, a…

…Objectives Methylprednisolone (mPSL) pulse therapy is an essential treatment for systemic lup…

…(OR 2.52, 95% CI 1.05–6.46). No associations were observed with hydroxychloroquine use.Abstract PO:02:032 Figure 1Conclusions Autoantibody-defined…

…onal biomarkers for monitoring SLE activity being components of SLEDAI-2K, they may be insufficient in distinguishing high disease activi…

…patientsConclusions In this real-world setting of SLE patients, belimumab treatment was associated with decreases in levels of key mediat…

… (29.4%) patients. Glucocorticoids were received by 41 (80.4%), hydroxychloroquine - 38 (74.5%), immunosuppressants – 18 (35.3%) patients. Over th…

… a saline suppression test in 2025 confirmed PA. Treatment with spironolactone (25mg daily, later increased to 37.5mg) is ongoing, with partia…

…essants: calcineurin inhibitors (3/5), mycophenolate (2/5), and belimumab (1/5). The most frequent extrarenal manifestations were arthrit…

…r organ activity, no new disease activity, PGA less than 1, and prednisone less than 7.5mg/day. Organ damage was measured with the SLICC/A…

…Objectives Belimumab (BEL), a B-cell modulator mAb that selectively inhibits soluble…

… I IFN, and revealed that, depending on the culture conditions, type I IFN can decrease galactosylation in B cells.Conclusions Taken toget…